Published in JAMA on July 18, 1980
Experience with routine reuse of plastic insulin syringes. Br Med J (Clin Res Ed) (1984) 1.50
Multiple use of ordinary disposable syringes for insulin injections. Br Med J (Clin Res Ed) (1982) 1.36
Plastic insulin syringes: reuse or waste pounds 8m a year. Br Med J (Clin Res Ed) (1988) 0.98
What makes insulin injections painful? BMJ (1991) 0.84
Disposable or non-disposable syringes and needles for diabetics? Strathclyde Diabetic Group. Br Med J (Clin Res Ed) (1983) 0.75
Insulin injections and infections. Br Med J (Clin Res Ed) (1981) 0.75
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA (1997) 8.24
Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA (1998) 8.02
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med (1992) 6.30
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med (1989) 6.29
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother (1974) 5.19
Sexual harassment in medical training. N Engl J Med (1993) 4.93
Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis (1979) 4.70
Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest (1978) 4.38
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med (2001) 3.75
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis (1975) 3.52
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med (1980) 3.03
Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis (2001) 2.87
Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis (1984) 2.77
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis (1974) 2.64
Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med (1989) 2.58
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med (1982) 2.52
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet (1989) 2.18
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med (2001) 2.17
Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study. JAMA (1990) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis (1985) 2.10
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
The HIV epidemic and training in internal medicine. Challenges and recommendations. N Engl J Med (1989) 2.06
Uncomplicated acute bronchitis. Ann Intern Med (2000) 2.06
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med (1998) 2.04
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis (1984) 2.00
Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control (1989) 1.98
Chronic traumatic thoracic aneurysm. Influence of operative treatment on natural history: an analysis of reported cases, 1950-1980. J Thorac Cardiovasc Surg (1982) 1.95
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest (1983) 1.93
Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. J Infect Dis (1988) 1.90
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother (1976) 1.89
Routine use of anaerobic blood cultures: are they still indicated? Am J Med (2000) 1.88
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis (1975) 1.88
Relation between surgical volume and incidence of postoperative wound infection. N Engl J Med (1981) 1.87
Comparative pharmacology of cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.86
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.85
Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium. N Engl J Med (1979) 1.84
Clinical effectiveness of influenza vaccination in Manitoba. JAMA (1993) 1.78
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med (1976) 1.73
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. Infect Immun (1983) 1.72
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.70
Cephalosporin antibiotics in therapy of experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis in rabbits. J Infect Dis (1978) 1.68
The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. J Infect Dis (1984) 1.67
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun (1978) 1.66
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother (1981) 1.66
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother (1985) 1.66
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med (1984) 1.64
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest (1980) 1.64
Postinfarction ventricular septal rupture: the importance of location of infarction and right ventricular function in determining survival. Circulation (1986) 1.63
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab (1987) 1.58
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis (1979) 1.57
Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med (1986) 1.56
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy. Infect Immun (1977) 1.56
Value of serum tests in combined drug therapy of endocarditis. Antimicrob Agents Chemother (1983) 1.56
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med (2001) 1.55
Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med (1972) 1.54
Health perceptions of primary care patients and the influence on health care utilization. Med Care (1989) 1.53
Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis (1979) 1.52
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother (1981) 1.51
In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother (1977) 1.51
Improving preventive care at a medical clinic: how can the patient help? Am J Prev Med (1990) 1.50
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis (1981) 1.49
Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol (1989) 1.48
Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation (1983) 1.46
Comparative pharmacology of josamycin and erythromycin stearate. Antimicrob Agents Chemother (1976) 1.46
Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis. J Infect Dis (1977) 1.46
Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest (1984) 1.46
Equestrian injuries. Results of a prospective study. JAMA (1978) 1.45
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol (1988) 1.43
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect Immun (1985) 1.40
Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) (1983) 1.39
Antibiotic therapy of bacterial meningitis: lessons we've learned. Am J Med (1981) 1.38
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Emerg Med (2001) 1.37
Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.37
Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax (1989) 1.36
Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun (1979) 1.36
Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis (1978) 1.36
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Antimicrob Agents Chemother (1980) 1.34
Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis (1987) 1.33
Contemporary aspects of discrete peak-detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev (1988) 1.33
Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest (1981) 1.31
Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol Suppl (1981) 1.30